Kopran P/E Ratio
Kopran (KOPRAN) P/E ratio is 31.53 (High), EPS (TTM) ₹5.33, current price ₹193.58 on NSE vs historical average P/E of 16.39 (88.9th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Kopran share price screener.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
KOPRAN P/E Ratio — Valuation Signal & Historical Context
Kopran P/E 31.53 vs historical average 16.39, range 2.62–42.82 — signal: Overvalued. Analyse KOPRAN shareholder distribution to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 31.53, suggesting caution for new investments
- Current PE is 92.4% above historical average
- Trading at discount to sector average PE of 49.14
Kopran P/E Ratio Historical Trend
KOPRAN annual price-to-earnings ratio — 9 years, EPS and year-end price. Current P/E 31.53 vs historical average 16.39. Browse KOPRAN financial statements for revenue, profit, balance sheet and cash flow data.
KOPRAN Historical P/E Ratio — EPS, Year-End Price & Valuation
Kopran annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 25.49 | 9.85 | ₹251.10 | NSE | High |
| 2023 | 17.76 | 8.39 | ₹149.00 | NSE | Moderate |
| 2022 | 42.82 | 7.67 | ₹328.40 | NSE | High |
| 2021 | 10.25 | 13.54 | ₹138.85 | NSE | Low |
| 2020 | 2.62 | 11.87 | ₹31.15 | NSE | Low |
| 2019 | 7.05 | 5.5 | ₹38.80 | NSE | Low |
| 2018 | 13.75 | 4.96 | ₹68.20 | NSE | Low |
| 2017 | 10.68 | 4.95 | ₹52.85 | NSE | Low |
| 2016 | 17.09 | 4.41 | ₹75.35 | NSE | Moderate |
KOPRAN vs Healthcare Peers — P/E Ratio Comparison
Kopran P/E 31.53 vs Healthcare average 49.14, median 28.77 — range 0.97–869.57.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |